138 related articles for article (PubMed ID: 7937523)
21. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
[TBL] [Abstract][Full Text] [Related]
22. Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates.
Srinivas RV; Robbins BL; Connelly MC; Gong YF; Bischofberger N; Fridland A
Antimicrob Agents Chemother; 1993 Oct; 37(10):2247-50. PubMed ID: 8257154
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir.
Zídek Z; Kmonícková E; Holý A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):315-9. PubMed ID: 16601779
[TBL] [Abstract][Full Text] [Related]
24. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys.
Balzarini J; Naesens L; Slachmuylders J; Niphuis H; Rosenberg I; Holý A; Schellekens H; De Clercq E
AIDS; 1991 Jan; 5(1):21-8. PubMed ID: 2059358
[TBL] [Abstract][Full Text] [Related]
25. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
[TBL] [Abstract][Full Text] [Related]
26. Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.
Hatse S; Naesens L; De Clercq E; Balzarini J
Biochem Pharmacol; 1998 Oct; 56(7):851-9. PubMed ID: 9774147
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
Lin CC; Xu C; Teng A; Yeh LT; Peterson J
J Clin Pharmacol; 2005 Nov; 45(11):1250-8. PubMed ID: 16239358
[TBL] [Abstract][Full Text] [Related]
28. Chemokines, nitric oxide and antiarthritic effects of 9-(2-phosphonomethoxyethyl)adenine (Adefovir).
Zídek Z; Franková D; Holý A
Eur J Pharmacol; 1999 Jul; 376(1-2):91-100. PubMed ID: 10440094
[TBL] [Abstract][Full Text] [Related]
29. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
Balzarini J; Hatse S; Naesens L; De Clercq E
Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia.
Dallas S; Schlichter L; Bendayan R
J Pharmacol Exp Ther; 2004 Jun; 309(3):1221-9. PubMed ID: 14762102
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
[TBL] [Abstract][Full Text] [Related]
32. Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.
Česnek M; Jansa P; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Brust TF; Pávek P; Trejtnar F; Watts VJ; Janeba Z
ChemMedChem; 2015 Aug; 10(8):1351-64. PubMed ID: 26136378
[TBL] [Abstract][Full Text] [Related]
33. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vivo evaluation of prodrugs of 9-[2-(phosphonomethoxy)ethoxy]adenine.
Serafinowska HT; Ashton RJ; Bailey S; Harnden MR; Jackson SM; Sutton D
J Med Chem; 1995 Apr; 38(8):1372-9. PubMed ID: 7731022
[TBL] [Abstract][Full Text] [Related]
35. Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered.
Balzarini J; Naesens L; De Clercq E
Int J Cancer; 1990 Aug; 46(2):337-40. PubMed ID: 2384280
[TBL] [Abstract][Full Text] [Related]
36. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells.
Robbins BL; Greenhaw J; Connelly MC; Fridland A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2304-8. PubMed ID: 8619586
[TBL] [Abstract][Full Text] [Related]
37. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
Naesens L; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):53-64. PubMed ID: 1776876
[TBL] [Abstract][Full Text] [Related]
38. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
Cerny J; Foster SA; Cheng YC
Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
[TBL] [Abstract][Full Text] [Related]
39. Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.
Zídek A; Holý A; Franková D; Otová B
Eur J Pharmacol; 1995 Nov; 286(3):307-10. PubMed ID: 8608793
[TBL] [Abstract][Full Text] [Related]
40. Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution.
Oliyai R; Yuan LC; Dahl T
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1295-8. PubMed ID: 11563007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
